A novel p21 attenuator which is structurally related to sorafenib. (Record no. 22402099)

MARC details
000 -LEADER
fixed length control field 01459 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516130709.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201308s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1555-8576
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.4161/cbt.23374
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Wettersten, Hiromi I
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20130819
245 00 - TITLE STATEMENT
Title A novel p21 attenuator which is structurally related to sorafenib.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer biology & therapy
Date of publication, distribution, etc. Mar 2013
300 ## - PHYSICAL DESCRIPTION
Extent 278-85 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Proliferation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclin-Dependent Kinase Inhibitor p21
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Niacinamide
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phenylurea Compounds
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element RNA, Messenger
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sorafenib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Suppressor Protein p53
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element raf Kinases
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hee Hwang, Sung
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, Cuiwen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shiu, Eunice Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wecksler, Aaron T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hammock, Bruce D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Weiss, Robert H
773 0# - HOST ITEM ENTRY
Title Cancer biology & therapy
Related parts vol. 14
-- no. 3
-- p. 278-85
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.4161/cbt.23374">https://doi.org/10.4161/cbt.23374</a>
Public note Available from publisher's website

No items available.